Skip Navigation



ToxSci Advance Access published online on May 29, 2009

Toxicological Sciences, doi:10.1093/toxsci/kfp108
This Article
Right arrow Advance Access manuscript (PDF)
Right arrow Supplementary Data
Right arrow All Versions of this Article:
110/2/319    most recent
kfp108v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Phillips, J. M.
Right arrow Articles by Goodman, J. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Phillips, J. M.
Right arrow Articles by Goodman, J. I.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org

The Constitutive Active/Androstane Receptor (CAR) Facilitates Unique Phenobarbital (PB)-Induced Expression Changes of Genes Involved in Key Pathways in Precancerous Liver and Liver Tumors

Jennifer M. Phillips*, Lyle D. Burgoon*,{dagger} and Jay I. Goodman{ddagger},1

* Department of Biochemistry and Molecular Biology {dagger} Gene Expression in Development and Disease Initiative {ddagger} Department of Pharmacology and Toxicology, and Center for Integrative Toxicology, Michigan State University, East Lansing, Michigan 48824

1 Corresponding Author: Jay I. Goodman, Michigan State University, B-440 Life Sciences Bldg. East Lansing, MI 48824, Email: goodman3{at}msu.edu, Tel: 517-353-9346, Fax: 517-353-8915

Received March 11, 2009; revision received May 19, 2009; accepted May 20, 2009


   Abstract

Our overall goal is to elucidate progressive changes, in expression and methylation status, of genes which play key roles in phenobarbital (PB)-induced liver tumorigenesis, with an emphasis on their potential to affect signaling through critical pathways involved in the regulation of cell growth and differentiation. PB-elicited unique expression changes of genes, including some of those identified previously as exhibiting regions of altered DNA methylation (Phillips and Goodman, 2009), were discerned in precancerous liver tissue and/or individual liver tumors from susceptible constitutive active/androstane receptor (CAR) wildtype (WT) compared to resistant CAR knockout (KO) mice. Many of these function in crucial cancer-related processes, e.g., angiogenesis, apoptosis, cell cycle, DNA methylation, Hedgehog signaling, invasion/metastasis, Notch signaling, and Wnt signaling. Furthermore, a subset of the uniquely altered genes contained CAR response elements (CAREs). This included Gadd45b, a coactivator of CAR and inhibitor of apoptosis, and 2 DNA methyltransferases (Dnmt1, Dnmt3a). The presence of CAREs in Dnmts suggests a potential direct link between PB and altered DNA methylation. The current data are juxtaposed with the effects of PB on DNA methylation and gene expression which occurred uniquely in liver tumor-prone B6C3F1 mice, as compared to the resistant C57BL/6, following 2- or 4-wk of treatment (Phillips and Goodman, 2008 and Phillips et al., 2009). Collectively, these data reveal a comprehensive view of PB-elicited molecular alterations (i.e. changes in gene expression and DNA methylation) that can facilitate hepatocarcinogenesis. Notably, candidate genes for initial "fingerprints" of early and late stages of PB-induced tumorigenesis are proposed.

Key Words: CAR; DNA methylation; gene expression; mouse liver; tumors.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.